ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1924

What Do Patients with Polmyalgia Rheumatica Mean When They Describe Stiffness? A Qualitative Study

Rodney A. Hughes1, Sarah Mackie2, John R. Kirwan3, Colin T. Pease4, Margaret Walsh1 and Marianne Morris5, 1Rheumatology, St. Peters Hospital, Chertsey Surrey, United Kingdom, 2Academic Unit of Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom, 3Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, United Kingdom, 4Department of Rheumatology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 5University of the West of England, Bristol, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Outcome measures and polymyalgia rheumatica

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Patients with PMR report significant symptoms of pain and stiffness.  Stiffness has usually been included in diagnostic criteria for PMR but has never been clearly defined.  Stiffness can prove difficult to measure and to distinguish from pain.  To try to establish both a definition and a clearer understanding of stiffness in PMR we have performed a qualitative study designed to elicit appropriate patient experience and perception of stiffness. 

Methods:

We have conducted 8 focus groups in 3 rheumatology centres in the UK involving 50 patients with PMR.  We included one city and two semi-urban units in three regions in the UK to try to explore differences in language or communication across areas.  Patients all had English as a first language.  Each focus group ran for 1.5 hours, data were transcribed and thematically analysed into codes, sub-themes and themes.  Two expert patients with PMR were included in the research from the start of the study.  Sample size was designed to reach saturation of themes.

Results:

Themes have emerged in response to direct questioning that relate specifically to definitions of stiffness and measurable outcomes for PMR (deductive thematic anaysis).  Through inductive analysis additional themes have emerged; that pain and stiffness were inextricably linked, the use of metaphors to describe PMR symptoms, and an in depth understanding of the cognitive and behavioural impact of polymyalgia.

PMR emerges as a disease of ‘two halves’ with a very close relationship between pain and stiffness.  For some, stiffness appears before pain is experienced and can serve as a warning of pain should the person move –‘freezing up in anticipation of pain’.  From the data set it appears that patients are dominated either by pain, fatigue or stiffness but there is always a background of stiffness. Metaphorical descriptions of disease relating to stiffness have included ‘tin soldier’, ‘rusty hinge’, ‘2 bricks cemented on my shoulders’ and being ‘trapped in a coffin’.  Patients report stiffness in association with sleep disturbance, loss of confidence, mood and stress disorders and a clear temporal variation of symptoms worse at night and in the early morning ‘my 24 hour problem’, ‘a cycle’.  Although patients report a very significant improvement in stiffness and pain after treatment with corticosteroids data suggest that they almost always continue to experience stiffness although they may not report this to their physicians.  Stiffness both before and after treatment impacts on function, independence and social and working life.

Conclusion:

This work has led us towards a clearer definition of the meaning, experience and impact of stiffness.  We have devised an initial thematic model of symptoms in polymyalgia that emerges from our work that will enable us to proceed further towards an adequate definition of stiffness ways of measuring it.

A thematic model of stiffness in PMR

https://acr.confex.comhttps://acrabstracts.org/wp-content/uploads/2014/10/Paper-26800-abstract-23301-0.gif

 


Disclosure:

R. A. Hughes,
None;

S. Mackie,
None;

J. R. Kirwan,

Horizon Pharma (formerly Nitec Pharma), AstraZeneca, CombinatoRx, GlaxoSmithKline, Merck, and Wyeth,

5;

C. T. Pease,
None;

M. Walsh,
None;

M. Morris,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-do-patients-with-polmyalgia-rheumatica-mean-when-they-describe-stiffness-a-qualitative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology